VTYX
Ventyx Biosciences Inc
NASDAQ: VTYX · HEALTHCARE · BIOTECHNOLOGY
$14.00
+0.00% today
Updated 2026-03-04
Market cap
$1.00B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$1 – $15
Volume
4.1M
Ventyx Biosciences Inc (VTYX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-2.64M | $-6.20M | $-38.65M | $-98.77M | $-166.52M | $-130.87M |
| Capital expenditures | $262000.00 | $262000.00 | $262000.00 | $275000.00 | $514000.00 | $241000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $198000.00 | $45000.00 | $2.73M | $16.57M | $28.59M | $22.93M |
| Free cash flow | $-2.90M | $-6.46M | $-38.91M | $-99.05M | $-167.04M | $-131.11M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | $70.55M | $-5.93M | — | — |